Badanie: Towards optimal treatment selection for borderline personality disorder patients (BOOTS): a study protocol for a multicenter randomized clinical trial comparing schema therapy and dialectical behavior therapy
Badacze: Carlijn J. M. Wibbelink, Arnoud Arntz, Raoul P. P. P. Grasman, Roland Sinnaeve, Michiel Boog, Odile M. C. Bremer, Eliane C. P. Dek, Sevinç Göral Alkan, Chrissy James, Annemieke M. Koppeschaar, Linda Kramer, Maria Ploegmakers, Arita Schaling, Faye I. Smits & Jan H. Kamphuis
Obszar badań: porównanie skuteczności terapii schematów i terapii dialektyczno-behawioralnej w leczeniu osób z borderline
Data publikacji: 2022 r.
Miejsce publikacji: BMC Psychiatry 22, 89 (2022)
Język artykułu: angielski
Abstrakt
„Specialized evidence-based treatments have been developed and evaluated for borderline personality disorder (BPD), including Dialectical Behavior Therapy (DBT) and Schema Therapy (ST). Individual differences in treatment response to both ST and DBT have been observed across studies, but the factors driving these differences are largely unknown. Understanding which treatment works best for whom and why remain central issues in Psychotherapy research. The aim of the present study is to improve treatment response of DBT and ST for BPD patients by a) identifying patient characteristics that predict (differential) treatment response (i.e., treatment selection) and b) understanding how both treatments lead to change (i.e., mechanisms of change). Moreover, the clinical effectiveness and cost-effectiveness of DBT and ST will be evaluated.”
Aby przejść na stronę, z której można pobrać pełną treść artykułu, kliknij poniższy przycisk:
Źródło opisu i artykułu: https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-021-03670-9